Detalhe da pesquisa
1.
Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cells.
Biotechnol Bioeng
; 112(11): 2267-75, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25943562
2.
Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency loss.
BMC Biotechnol
; 14: 111, 2014 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25540031
3.
Stabilization of HIV-1 envelope in the CD4-bound conformation through specific cross-linking of a CD4 mimetic.
J Biol Chem
; 286(24): 21706-16, 2011 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21487012
4.
Structural evidence of glycoprotein assembly in cellular membrane compartments prior to Alphavirus budding.
J Virol
; 84(21): 11145-51, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20739526
5.
Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant.
J Virol
; 84(12): 5975-85, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20392857
6.
Glycobiotechnology of the Insect Cell-Baculovirus Expression System Technology.
Adv Biochem Eng Biotechnol
; 175: 71-92, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-29886511
7.
Characterization of immune responses elicited in macaques immunized sequentially with chimeric VEE/SIN alphavirus replicon particles expressing SIVGag and/or HIVEnv and with recombinant HIVgp140Env protein.
AIDS Res Hum Retroviruses
; 22(10): 1022-30, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17067273
8.
Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 (HIV-1) subtypes B and C.
Microbes Infect
; 7(14): 1386-91, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16275150
9.
Gene vaccines.
Ann Intern Med
; 138(7): 550-9, 2003 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12667025
10.
Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolate.
Vaccine
; 33(44): 6011-6, 2015 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26409814
11.
Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein.
PLoS One
; 10(6): e0128562, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26087072
12.
Immunogenicity of HIV-1 Env and Gag in baboons using a DNA prime/protein boost regimen.
AIDS
; 18(7): 991-1001, 2004 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-15096801
13.
Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design.
Expert Rev Vaccines
; 3(4 Suppl): S33-52, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15285704
14.
Mechanism of a decrease in potency for the recombinant influenza A virus hemagglutinin H3 antigen during storage.
J Pharm Sci
; 103(3): 821-7, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24425059
15.
Trimeric HIV Env provides epitope occlusion mediated by hypervariable loops.
Sci Rep
; 4: 7025, 2014 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25395053
16.
Development of a stable virus-like particle vaccine formulation against Chikungunya virus and investigation of the effects of polyanions.
J Pharm Sci
; 102(12): 4305-14, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24129946
17.
Putative role of Tat-Env interaction in HIV infection.
AIDS
; 27(15): 2345-54, 2013 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23835500
18.
Stabilizing exposure of conserved epitopes by structure guided insertion of disulfide bond in HIV-1 envelope glycoprotein.
PLoS One
; 8(10): e76139, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24146829
19.
Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein.
Vaccine
; 30(17): 2749-59, 2012 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22366638
20.
Elicitation of neutralizing antibodies directed against CD4-induced epitope(s) using a CD4 mimetic cross-linked to a HIV-1 envelope glycoprotein.
PLoS One
; 7(1): e30233, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22291921